Tirzepatide leads to greater weight loss than semaglutide among adults with obesity
1. In this randomized controlled trial, among adults with obesity, it was found that tirzepatide resulted in a significantly greater ...
Tag: Tirzepatide
Lilly Strikes $1.3 Billion GPCR Drug Discovery Pact with Superluminal
Key Points: 1. Deal worth up to $1.3 billion brings AI-powered GPCR target discovery into Lilly’s obesity and cardiometabolic pipeline. ...
Tirzepatide-associated improvements in cardiometabolic risk factors linked to degree of weight loss
1. In this post-hoc analysis of the SURMOUNT-1 trial, there was a mostly linear relationship between percentage change in weight ...
#VisualAbstract: Tirzepatide Superior to Semaglutide in Obese Adults Without Diabetes
Click here to read this study in NEJM. ©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
Tirzepatide reduces obstructive sleep apnea symptoms and associated risks
1. In this randomized controlled trial, in patients with both moderate-severe obstructive sleep apnea (OSA) and obesity, it was found ...
#VisualAbstract: Tirzepatide Improved Outcomes in Patients with Obstructive Sleep Apnea and Obesity
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
#VisualAbstract: Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis (MASH) with Liver Fibrosis was More Effective Than Placebo at Resolving MASH
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be ...
Eli Lilly: Tirzepatide Shows Promise In Treating Obstructive Sleep Apnea In Two Phase 3 Clinical Trials
Tirzepatide led to a 63% mean reduction in restricted/obstructed breathing events per hour in patients with moderate to severe obstructive ...
#VisualAbstract: Once-weekly tirzepatide significantly improves weight and glycemic control in patients with with obesity and type 2 diabetes
Click to read the study in The Lancet ©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
Once-weekly tirzepatide significantly improves weight and glycemic control in patients with with obesity and type 2 diabetes
1. Body weight reduction at week 72 was significantly greater with tirzepatide versus placebo. 2. Hemoglobin A1c was significantly reduced ...
